iBio, Inc. (IBIO)

iBio, Inc. Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	28.67	8.58	14.21	4.3	22.68	77.4
Short-Term Investments	24.03	-	-	-	10.85	19.57
Cash & Short-Term Investments	52.7	8.58	14.21	4.3	33.52	96.97
Cash Growth	651.22%	-39.61%	230.39%	-87.17%	-65.43%	75.96%
Accounts Receivable	-	-	-	-	1	0.43
Other Receivables	0.67	0.11	0.71	0.87	5.1	5.1
Total Trade Receivables	0.67	0.11	0.71	0.87	6.1	5.53
Inventory	-	-	-	-	-	0.03
Other Current Assets	-	1.03	0.75	21.09	5.45	2.07
Total Current Assets	53.37	9.72	15.67	26.26	45.07	104.6
Net Property, Plant & Equipment	5.38	5.21	6.37	7.55	4.44	34.74
Other Intangible Assets	4.34	6.85	5.37	5.39	4.85	0.95
Other Long-Term Assets	1.38	1.33	1.32	2.01	45.04	6.68
Total Assets	64.39	23.19	28.73	41.21	99.41	146.97
Accounts Payable	2.65	2.19	0.36	1.85	4.26	2.25
Accrued Expenses	1.58	1.35	2.03	4.56	3.76	3
Short-Term Debt	-	-	0.12	12.94	-	-
Current Portion of Long-Term Debt	-	0.83	0.4	0.16	22.16	0.6
Current Portion of Leases	0.52	0.54	0.74	0.66	0.09	0.37
Unearned Revenue	1.15	1.2	0.2	-	0.1	0.42
Other Current Liabilities	-	-	-	1.94	0.06	-
Total Current Liabilities	5.9	6.11	3.84	22.11	30.44	6.65
Long-Term Debt	-	-	0.83	0.24	-	-
Long-Term Leases	1.93	2.2	2.74	3.48	3.51	31.76
Other Long-Term Liabilities	-	-	-	-	1.97	-
Total Long-Term Liabilities	1.93	2.2	3.57	3.72	5.49	31.76
Total Liabilities	7.83	8.31	7.41	25.83	35.92	38.4
Common Stock	0.03	0.02	0.01	0	0.01	0.01
Additional Paid-in Capital	403.46	347.09	335.16	304.32	287.62	282.27
Accumulated Other Comprehensive Income	0.01	-	-	-	-0.21	-0.06
Retained Earnings	-346.94	-332.22	-313.85	-288.94	-223.93	-173.63
Total Common Shareholders' Equity	56.56	14.88	21.32	15.38	63.49	108.59
Minority Interest	-	-	-	-	-	-0.02
Shareholders' Equity	56.56	14.88	21.32	15.38	63.49	217.15
Total Liabilities & Equity	64.39	23.19	28.73	41.21	99.41	146.97
Total Debt	2.45	3.57	4.82	17.48	25.77	32.72
Net Cash (Debt)	50.25	5.01	9.39	-13.17	7.76	64.25
Net Cash Growth	902.95%	-46.62%	-	-	-87.93%	189.37%
Net Cash Per Share	1.14	0.48	2.45	-21.53	17.79	164.22
Book Value	56.56	14.88	21.32	15.38	63.49	108.59
Book Value Per Share	1.28	1.42	5.57	25.13	145.59	277.53
Tangible Book Value	52.22	8.03	15.96	9.99	58.63	107.63
Tangible Book Value Per Share	1.18	0.77	4.16	16.33	134.47	275.10

Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q